Altering cannabinoid signaling during development disrupts neuronal activity
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
In adult cortical tissue, recruitment of GABAergic inhibition prevents the progression of synchronous population discharges to epileptic activity. However, at early developmental stages, GABA is excitatory and thus unable to fulfill this role. Here, we report that retrograde signaling involving endocannabinoids is responsible for the homeostatic control of synaptic transmission and the resulting network patterns in the immature hippocampus. Blockade of cannabinoid type 1 (CB1) receptor led to epileptic discharges, whereas overactivation of CB1 reduced network activity in vivo . Endocannabinoid signaling thus is able to keep population discharge patterns within a narrow physiological time window, balancing between epilepsy on one side and sparse activity on the other, which may result in impaired developmental plasticity. Disturbing this delicate balance during pregnancy in either direction, e.g., with marijuana as a CB1 agonist or with an antagonist marketed as an antiobesity drug, can have profound consequences for brain maturation even in human embryos.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CGE-derived interneurons certainly play a role in GDP generation.”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [98]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“endocannabinoid agonists suppress GDPs while antagonists increase their frequency, strongly implying the participation of CGE-derived CCK-containing interneurons”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4<347::aid-hipo1>3.0.co;2-i · Cited by 3,441
Self-citationExcitatory actions of gaba during development: the nature of the nurture
Ben-Ari, Y. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn920 · Cited by 2,448
Self-citationEndogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Role of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Self-citationGiant synaptic potentials in immature rat CA3 hippocampal neurones.
Ben‐Ari, Y., Cherubini, E., Corradetti, R., & Gaiarsa, J. L. (1989) · The Journal of Physiology · doi:10.1113/jphysiol.1989.sp017762 · Cited by 1,317
Self-citationTranslating developmental time across mammalian species
Clancy, B., Darlington, R. B., & Finlay, B. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00171-3 · Cited by 1,221
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citationCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Heterosynaptic LTD of Hippocampal GABAergic Synapses
Chevaleyre, V., & Castillo, P. E. (2003) · Neuron · doi:10.1016/s0896-6273(03)00235-6 · Cited by 655
Research works printed but not linked: 1
- Fergusson, D. M., Horwood, L. J. & Northstone, K. (2002) Br. J. Obstet. Gynaecol. 109, 21-27. [DOI] [PubMed] [Google Scholar] · doi:10.1111/j.1471-0528.2002.01020.x · Paper page
Cited by
GABA: A Pioneer Transmitter That Excites Immature Neurons and Generates Primitive Oscillations
Ben-Ari, Y., Gaiarsa, J.-L., Tyzio, R., & Khazipov, R. (2007) · Physiological Reviews · doi:10.1152/physrev.00017.2006 · Cited by 1,304
Self-citationHippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
The emerging functions of endocannabinoid signaling during CNS development
Harkany, T., Guzmán, M., Galve-Roperh, I., Berghuis, P., Devi, L. A., & Mackie, K. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.004 · Cited by 432
Cannabinoids reveal importance of spike timing coordination in hippocampal function
Robbe, D., Montgomery, S. M., Thome, A., Rueda-Orozco, P. E., McNaughton, B. L., & Buzsaki, G. (2006) · Nature Neuroscience · doi:10.1038/nn1801 · Cited by 333
Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509494102 · Cited by 291
Pelkey, K. A., Barksdale, E., Craig, M. T., Yuan, X., Sukumaran, M., Vargish, G. A., Mitchell, R. M., Wyeth, M. S., Petralia, R. S., Chittajallu, R., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.020 · Cited by 245
Ludányi, A., Erőss, L., Czirják, S., Vajda, J., Halász, P., Watanabe, M., Palkovits, M., Maglóczky, Z., Freund, T. F., & Katona, I. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4465-07.2008 · Cited by 243
Self-citationVanhatalo, S., Palva, J. M., Andersson, S., Rivera, C., Voipio, J., & Kaila, K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04459.x · Cited by 230
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Perucca, E. (2017) · Journal of Epilepsy Research · doi:10.14581/jer.17012 · Cited by 223
Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation
Palazuelos, J., Aguado, T., Egia, A., Mechoulam, R., Guzmán, M., Galve‐Roperh, I., Palazuelos, J., Aguado, T., Egia, A., Mechoulam, R., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6164fje · Cited by 221
Prenatal Marijuana Exposure and Intelligence Test Performance at Age 6
GOLDSCHMIDT, L., RICHARDSON, G. A., WILLFORD, J., & DAY, N. L. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318160b3f0 · Cited by 187
Endocannabinoid functions controlling neuronal specification during brain development
Harkany, T., Keimpema, E., Barabás, K., & Mulder, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.02.011 · Cited by 186
Jutras-Aswad, D., DiNieri, J. A., Harkany, T., & Hurd, Y. L. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0027-z · Cited by 184
Tolner, E. A., Sheikh, A., Yukin, A. Y., Kaila, K., & Kanold, P. O. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1538-11.2012 · Cited by 179
Robbe, D., & Buzsáki, G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2407-09.2009 · Cited by 170
de Salas-Quiroga, A., Díaz-Alonso, J., García-Rincón, D., Remmers, F., Vega, D., Gómez-Cañas, M., Lutz, B., Guzmán, M., & Galve-Roperh, I. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514962112 · Cited by 152
Suárez, J., Llorente, R., Romero‐Zerbo, S. Y., Mateos, B., Bermúdez‐Silva, F. J., de Fonseca, F. R., & Viveros, M. (2009) · Hippocampus · doi:10.1002/hipo.20537 · Cited by 140
Chen, K., Neu, A., Howard, A. L., Földy, C., Echegoyen, J., Hilgenberg, L., Smith, M., Mackie, K., & Soltesz, I. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3966-06.2007 · Cited by 158
Haspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 156
Developmental changes in GABAergic mechanisms in human visual cortex across the lifespan
Pinto (2010) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2010.00016 · Cited by 131
Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders
Ben‐Ari, Y. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.002 · Cited by 148
Self-citationWiring and firing neuronal networks: endocannabinoids take center stage
Harkany, T., Mackie, K., & Doherty, P. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.08.007 · Cited by 145
Hill, A. J., Weston, S. E., Jones, N. A., Smith, I., Bevan, S. A., Williamson, E. M., Stephens, G. J., Williams, C. M., & Whalley, B. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02523.x · Cited by 119
Galve‐Roperh, I., Palazuelos, J., Aguado, T., & Guzmán, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0028-y · Cited by 126
Farkas, I., Kalló, I., Deli, L., Vida, B., Hrabovszky, E., Fekete, C., Moenter, S. M., Watanabe, M., & Liposits, Z. (2010) · Endocrinology · doi:10.1210/en.2010-0638 · Cited by 124
Cha, Y. M., Jones, K. H., Kuhn, C. M., Wilson, W. A., & Swartzwelder, H. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee7b7e · Cited by 108
Neuroimaging of children following prenatal drug exposure
Derauf, C., Kekatpure, M., Neyzi, N., Lester, B., & Kosofsky, B. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.03.001 · Cited by 122
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 116
Type-1 Cannabinoid Receptor Signaling in Neuronal Development
Gaffuri, A.-L., Ladarre, D., & Lenkei, Z. (2012) · Pharmacology · doi:10.1159/000339075 · Cited by 99
Consequences of Perinatal Cannabis Exposure
Scheyer, A. F., Melis, M., Trezza, V., & Manzoni, O. J. J. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.08.010 · Cited by 98
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Kofalvi, A. (2017) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 87
Subbanna, S., Shivakumar, M., Psychoyos, D., Xie, S., & Basavarajappa, B. S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3786-12.2013 · Cited by 102
Endocannabinoids via CB1receptors act as neurogenic niche cues during cortical development
Díaz-Alonso, J., Guzmán, M., & Galve-Roperh, I. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0385 · Cited by 94
Zurolo, E., Iyer, A. M., Spliet, W. G. M., van Rijen, P. C., Troost, D., Gorter, J. A., & Aronica, E. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.004 · Cited by 104
Alpár, A., Marzo, V. D., & Harkany, T. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.009 · Cited by 101
Llorente, R., Llorente‐Berzal, A., Petrosino, S., Marco, E., Guaza, C., Prada, C., López‐Gallardo, M., Di Marzo, V., & Viveros, M. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20666 · Cited by 84
Choi, K., Le, T., McGuire, J., Xing, G., Zhang, L., Li, H., Parker, C. C., Johnson, L. R., & Ursano, R. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.021 · Cited by 84
Lee, T. T. ‐., & Gorzalka, B. B. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.006 · Cited by 86
Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity
Hansen, H. H., Krutz, B., Sifringer, M., Stefovska, V., Bittigau, P., Pragst, F., Marsicano, G., Lutz, B., & Ikonomidou, C. (2008) · Annals of Neurology · doi:10.1002/ana.21287 · Cited by 79
Effect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study
van Dijk, D., Koeter, M. W. J., Hijman, R., Kahn, R. S., & van den Brink, W. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.01.016 · Cited by 82
Developmental regulation of fear learning and anxiety behavior by endocannabinoids
Lee, T. T. ‐., Hill, M. N., & Lee, F. S. (2016) · Genes, Brain and Behavior · doi:10.1111/gbb.12253 · Cited by 67
Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects
Bifulco, M., Grimaldi, C., Gazzerro, P., Pisanti, S., & Santoro, A. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033118 · Cited by 77
Regulation of excitability and plasticity by endocannabinoids and PKA in developing hippocampus
Yasuda, H., Huang, Y., & Tsumoto, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708349105 · Cited by 65
Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure
Grewen, K., Salzwedel, A. P., & Gao, W. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00601 · Cited by 72
Howard, A. L., Neu, A., Morgan, R. J., Echegoyen, J. C., & Soltesz, I. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00509.2006 · Cited by 70
Wood, J. T., Williams, J. S., Pandarinathan, L., Courville, A., Keplinger, M. R., Janero, D. R., Vouros, P., Makriyannis, A., & Lammi-Keefe, C. J. (2008) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2008.242 · Cited by 71
What is the mechanism whereby cannabis use increases risk of psychosis?
Luzi, S., Morrison, P. D., Powell, J. F., Forti, M. D., & Murray, R. M. (2008) · Neurotoxicity Research · doi:10.1007/bf03033802 · Cited by 70
Eggan, S. M., Mizoguchi, Y., Stoyak, S. R., & Lewis, D. A. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp179 · Cited by 67
Scheyer, A. F., Borsoï, M., Wager‐Miller, J., Pélissier‐Alicot, A., Murphy, M. N., Mackie, K., & Manzoni, O. J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.08.023 · Cited by 71
Regulation of neurite outgrowth by Gi/o signaling pathways
Kenneth, D. B. (2008) · Frontiers in bioscience · doi:10.2741/3022 · Cited by 68
Huang, Y. Y., Yasuda, H., Sarihi, A., & Tsumoto, T. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0899-08.2008 · Cited by 67
Shouman, B., Fontaine, R. H., Baud, O., Schwendimann, L., Keller, M., Spedding, M., Lelièvre, V., & Gressèns, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706755 · Cited by 63
Targeting the endocannabinoid system in treating brain disorders
Bahr, B. A., Karanian, D. A., Makanji, S. S., & Makriyannis, A. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.4.351 · Cited by 63
Jia, J., Ma, L., Wu, M., Zhang, L., Zhang, X., Zhai, Q., Jiang, T., Wang, Q., & Xiong, L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/893516 · Cited by 61
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Melis, M., & Pistis, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793612 · Cited by 53
Cannabinoid receptor type 1 expression during postnatal development of the rat retina
Zabouri, N., Bouchard, J., & Casanova, C. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22534 · Cited by 58
Suárez, J., Rivera, P., Llorente, R., Romero‐Zerbo, S., Bermúdez‐Silva, F. J., de Fonseca, F. R., & Viveros, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.042 · Cited by 56
Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats
Huizenga, M. N., Wicker, E., Beck, V. C., & Forcelli, P. A. (2017) · Epilepsia · doi:10.1111/epi.13842 · Cited by 56
Silva, L., Zhao, N., Popp, S., & Dow-Edwards, D. L. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.10.006 · Cited by 55
Coiret, G., Ster, J., Grewe, B. F., Wendling, F., Helmchen, F., Gerber, U. R., & Benquet, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037320 · Cited by 51
Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex
Deshmukh, S., Onozuka, K., Bender, K. J., Bender, V. A., Lutz, B., Mackie, K., & Feldman, D. E. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.033 · Cited by 48
Wester, J. C., & McBain, C. J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.4000-15.2016 · Cited by 46
Ferber, S. G., Trezza, V., & Weller, A. (2019) · Developmental Psychobiology · doi:10.1002/dev.21944 · Cited by 45
Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons
Albayram, Ö., Passlick, S., Bilkei-Gorzo, A., Zimmer, A., & Steinhäuser, C. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1782-5 · Cited by 42
The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System
Martínez-Peña, A. A., Perono, G. A., Gritis, S. A., Sharma, R., Selvakumar, S., Walker, O. S., Gurm, H., Holloway, A. C., & Raha, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168576 · Cited by 43
López‐Gallardo, M., Llorente, R., Llorente‐Berzal, A., Marco, E. M., Prada, C., Marzo, V. D., & Viveros, M. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20672 · Cited by 42
Los productos de Cannabis sativa: situación actual y perspectivas en medicina
Carranza, R. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 41
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 39
Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis
Armstrong, C., Morgan, R. J., & Soltész, I. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02173.x · Cited by 37
García‐Cabrerizo, R., & García-Fuster, M. J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.018 · Cited by 37
Ramírez-López, M. T., Vázquez, M., Bîndilă, L., Lomazzo, E., Hofmann, C., Blanco, R. N., Alén, F., Antón, M., Decara, J. M., Arco, R., et al. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00208 · Cited by 36
Gómez‐Ruíz, M., Hernández, M., & Fernández‐Ruíz, J. (2008) · Cell Adhesion & Migration · doi:10.4161/cam.2.4.6749 · Cited by 35
Nitric Oxide Signaling Modulates Synaptic Transmission during Early Postnatal Development
Cserép, C., Szőnyi, A., Veres, J. M., Nemeth, B., Szabadits, E., de Vente, J., Hájos, N., Freund, T. F., & Nyíri, G. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhq281 · Cited by 35
Self-citationCattani, A. A., Bonfardin, V. D., Represa, A., Ben-Ari, Y., & Aniksztejn, L. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00378.2007 · Cited by 29
Self-citationFerraro, L., Tomasini, M. C., Beggiato, S., Gaetani, S., Cassano, T., Cuomo, V., Amoroso, S., Tanganelli, S., & Antonelli, T. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0230-0 · Cited by 34
Keimpema, E., Calvigioni, D., & Harkany, T. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130117 · Cited by 32
Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
Beiersdorf, J., Hevesi, Z., Calvigioni, D., Pyszkowski, J., Romanov, R. A., Szodorai, E., Lübec, G., Shirran, S. L., Botting, C. H., Kasper, S. F., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135418 · Cited by 30
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity
Panja, D., Vedeler, C. A., & Schubert, M. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12492 · Cited by 29
Warrier, A., & Wilson, M. (2007) · Visual Neuroscience · doi:10.1017/s0952523807230160 · Cited by 29
Soderstrom, K., & Tian, Q. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20963 · Cited by 28
GABA imaging in brain slices using immobilized enzyme-linked photoanalysis
Morishima, T., Uematsu, M., Furukawa, T., Yanagawa, Y., Fukuda, A., & Yoshida, S. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.04.005 · Cited by 26
Medical marijuana laws and pregnancy: implications for public health policy
Chasnoff, I. J. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.07.010 · Cited by 26
Ramírez-López, M. T., Vázquez, M., Lomazzo, E., Hofmann, C., Blanco, R. N., Alén, F., Antón, M., Decara, J. M., Arco, R., Orío, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174307 · Cited by 26
Endocannabinoid system contributions to sex-specific adolescent neurodevelopment
Simone, J. J., Green, M. R., & McCormick, C. M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110438 · Cited by 26
Lee, T. T.-Y., & Gorzalka, B. B. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.09.002 · Cited by 26
Cannabinoid-dependent potentiation of inhibition at eye opening in mouse V1
Garkun, Y., & Maffei, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00046 · Cited by 26
Graf, W. D., Kekatpure, M. V., & Kosofsky, B. E. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52891-9.00014-2 · Cited by 25
Socała, K., Jakubiec, M., Abram, M., Mlost, J., Starowicz, K., Kamiński, R. M., Ciepiela, K., Andres‐Mach, M., Zagaja, M. P., Metcalf, C. S., et al. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102634 · Cited by 24
Alterations in synaptic function in epilepsy
Bernard, C. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02828.x · Cited by 24
Self-citationGonzalez-Islas, C. E., García-Bereguiain, M. Á., & Wenner, P. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1229-12.2012 · Cited by 24
Neuro-glial cannabinoid receptors modulate signaling in the embryonic avian retina
Kubrusly, R. C. C., Günter, A., Sampaio, L. D. S., Martins, R. S., Schitine, C., Trindade, P., Fernandes, A., Borelli-Tôrres, R. T., Miya-Coreixas, V. S., Costa, A. C. R., et al. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.10.016 · Cited by 23
Pelkey, K. A., Barksdale, E., Craig, M. T., Yuan, X., Sukumaran, M., Vargish, G. A., Mitchell, R. M., Wyeth, M. S., Petralia, R. S., Chittajallu, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.024 · Cited by 22
Early Exposure to THC Alters M-Cell Development in Zebrafish Embryos
Amin, M. R., Ahmed, K. T., & Ali, D. W. (2020) · Biomedicines · doi:10.3390/biomedicines8010005 · Cited by 21
Targeting Endocannabinoid System in Epilepsy: For Good or for Bad
Martínez-Aguirre, C., Çınar, R., & Rocha, L. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.12.013 · Cited by 20
In uterocannabinoid exposure alters breathing and the response to hypoxia in newborn mice
Tree, K., di Perrotolo, M. S., Peyronnet, J., & Cayetanot, F. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12588 · Cited by 20
Zamberletti, E., & Rubino, T. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.06.013 · Cited by 20
Keimpema, E., Straiker, A. J., Mackie, K., Harkany, T., & Hjerling‐Leffler, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224386 · Cited by 20
Buwembo, A., Long, H., & Walker, C. D. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.057 · Cited by 19
Lafreniere, J. D., & Kelly, M. E. M. (2018) · Neuronal Signaling · doi:10.1042/ns20170144 · Cited by 18
Endocannabinoid system protects against cryptogenic seizures
van Rijn, C. M., Perescis Martin, F. J., Vinogradova, L. V., & van, L. G. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70411-x · Cited by 18
Metadata
- Authors
- Bernard, C., Milh, M., Morozov, Y. M., Ben-Ari, Y., Freund, T. F., & Gozlan, H.
- Affiliations
- Inserm (FR)
- Institut de Neurobiologie de la Méditerranée–Institut National de la Santé et de la Recherche Médicale U29, 163 Route de Luminy BP13, 13273 Marseille Cédex 09, France; and Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 8., Szigony u. 43, H-1083, Hungary
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-06-17
- Volume
- 102
- Issue
- 26
- Pages
- 9388-9393
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1166590
- OpenAlex
- W2078267242
- Cited by
- 144
- References
- 35
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 5 · 2012: 11
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- endocannabinoids, cannabinoid type 1 receptor, CB1 receptor, GABAergic inhibition, epileptic discharges, synaptic homeostasis, immature hippocampus, neuronal network activity, developmental plasticity, prenatal cannabinoid exposure, cannabis, anti-obesity drugs, brain maturation
- MeSH terms
- Rimonabant, Animals, Brain, Cannabis, Electrodes, Electrophysiology, Female, Hippocampus, Immunohistochemistry, Male, Microscopy, Electron, Neurons, Piperidines, Pyrazoles, Receptors, GABA-A, Time Factors, Signal Transduction, Rats, Wistar, Substance-Related Disorders, Receptor, Cannabinoid, CB1, Rats, Cannabinoid Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.